The DOI matches its Crossref record; 327 of the 327 references it cites were found in a registry or an index.
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Open accessAbstract
This comprehensive, pedagogically-oriented review is aimed at a heterogeneous audience representative of the allied disciplines involved in research and patient care. After a foreword on epidemiology, genetics, and risk factors, the amyloid cascade model is introduced and the main neuropathological hallmarks are discussed. The progression of memory, language, visual processing, executive, attentional, and praxis deficits, and of behavioral symptoms is presented. After a summary on neuropsychological assessment, emerging biomarkers from cerebrospinal fluid assays, magnetic resonance imaging, nuclear medicine, and electrophysiology are discussed. Existing treatments are briefly reviewed, followed by an introduction to emerging disease-modifying therapies such as secretase modulators, inhibitors of Abeta aggregation, immunotherapy, inhibitors of tau protein phosphorylation, and delivery of nerve growth factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–327 of 327
The Hopkins Verbal Learning Test and Screening for Dementia
Hogervorst, E., Combrinck, M. I., Lapuerta, P., Rue, J. E., Swales, K., & Budge, M. M. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048628 · Cited by 127
Gilley, D. W., Bienias, J. L., WILSON, R. S., Bennett, D. A., Beck, T. L., & Evans, D. A. (2004) · Psychological Medicine · doi:10.1017/s0033291703001831 · Cited by 125
Lai, M. K. P., Tsang, S. W., Alder, J. T., Keene, J., Hope, T., Esiri, M. M., Francis, P. T., & Chen, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2077-2 · Cited by 125
Self-consciousness and Alzheimer's disease
Gil, R., Arroyo-Anlló, E. M., Ingrand, P., Gil, M., Neau, J. ‐., Ornon, C., & Bonnaud, V. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00280.x · Cited by 123
Genetics of Alzheimer's Disease. A Rapidly Evolving Field
Serretti, A., Olgiati, P., & Ronchi, D. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12108 · Cited by 119
Genetics, Transcriptomics, and Proteomics of Alzheimers Disease
Papassotiropoulos, A., Fountoulakis, M., Dunckley, T. L., Stephan, D. A., & Reiman, E. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0418 · Cited by 119
Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease
Doody, R. S., Dunn, J. K., Clark, C. M., Farlow, M., Foster, N. L., Liao, T., Gonzales, N., Lai, E., & Massman, P. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051272 · Cited by 118
Change in Depressive Symptoms During the Prodromal Phase of Alzheimer Disease
Wilson, R. S., Arnold, S. E., Beck, T. L., Bienias, J. L., & Bennett, D. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.439 · Cited by 118
Everyday Memory Impairment of Patients with Mild Cognitive Impairment
Kazui, H., Matsuda, A., Hirono, N., Mori, E., Miyoshi, N., Ogino, A., Tokunaga, H., Ikejiri, Y., & Takeda, M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084559 · Cited by 118
γ-Secretase Substrate Concentration Modulates the Aβ42/Aβ40 Ratio
Yin, Y. I., Bassit, B., Zhu, L., Yang, X., Wang, C., & Li, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704601200 · Cited by 117
Teng, E., Ringman, J. M., Ross, L., Mulnard, R. A., Dick, M. B., Bartzokis, G., Davies, H. D., Galasko, D. R., Hewett, L., Mungas, D., et al. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318165dbae · Cited by 115
Education, cognitive function, and severity of neuropathology in Alzheimer disease
Koepsell, T. D., Kurland, B. F., Harel, O., Johnson, E. A., Zhou, X. H., & Kukull, W. A. (2008) · Neurology · doi:10.1212/01.wnl.0000284603.85621.aa · Cited by 115
Postina, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954668 · Cited by 112
Yoshiura, T., Mihara, F., Ogomori, K., Tanaka, A., Kaneko, K., & Masuda, K. (2002) · Neuroreport · doi:10.1097/00001756-200212030-00026 · Cited by 112
Prevalence and clinical correlates of pathological affective display in Alzheimer's disease.
STARKSTEIN, S. E., Migliorelli, R., Teson, A., Petracca, G., Chemerinski, E., Manes, F. F., & Leiguarda, R. C. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.1.55 · Cited by 111
Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis
Zhou, B., Teramukai, S., & Fukushima, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099037 · Cited by 111
Moulin, C. J. A., James, N., Freeman, J. E., & Jones, R. W. (2003) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.26.1.1.23940 · Cited by 108
BACE1 Structure and Function in Health and Alzheimers Disease
Cole, S., & Vassar, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954758 · Cited by 107
Amyloid imaging in Alzheimer??s disease
Nordberg, A. K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281a47744 · Cited by 107
The neuropathological changes associated with normal brain aging.
Hof, P. R., Glannakopoulos, P., & Bouras, C. (1996) · PubMed · Cited by 106
Nerve Growth Factor Gene Therapy in Alzheimer Disease
Tuszynski, M. H. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318068d6d2 · Cited by 106
GSK-3 inhibitors for Alzheimer’s disease
Ávila, J., & Hernández, F. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1527 · Cited by 106
Supplemental Use of Antioxidant Vitamins and Subsequent Risk of Cognitive Decline and Dementia
Maxwell, C. J., Hicks, M. S., Hogan, D. B., Basran, J., & Ebly, E. M. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000085074 · Cited by 105
Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease
Soo Borson, B., & Raskind, M. A. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_6.17s · Cited by 105
Amieva, H., Lafont, S., Rouch‐Leroyer, I., Rainville, C. M., Dartigues, J., Orgogozo, J., & Fabrigoule, C. (2003) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2003.09.006 · Cited by 104
Estrogen Facilitates Neurite Extension via Apolipoprotein E in Cultured Adult Mouse Cortical Neurons
Nathan, B. P., Barsukova, A. G., Shen, F., McAsey, M. E., & Struble, R. G. (2004) · Endocrinology · doi:10.1210/en.2003-1707 · Cited by 103
Filoteo, J. V., Delis, D. C., Massman, P. J., Demadura, T. L., Butters, N., & Salmon, D. P. (1992) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639208402541 · Cited by 103
Forlenza, O. V., Spink, J. M., Dayanandan, R., Anderton, B. H., Olesen, O. F., & Lovestone, S. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070034 · Cited by 101
Bigler, E. D., Rosa, L., Schultz, F., Hall, S., & Harris, J. L. (1989) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198903)45:2<277::aid-jclp2270450216>3.0.co;2-m · Cited by 100
Cummings, J. L., Koumaras, B., Chen, M. J., & Mirski, D. F. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/s1543-5946(05)80020-0 · Cited by 99
Sustained Attention in Mild Alzheimer's Disease
Berardi, A. M., Parasuraman, R., & Haxby, J. V. (2005) · Developmental Neuropsychology · doi:10.1207/s15326942dn2801_4 · Cited by 99
Caroli, A., Testa, C., Geroldi, C., Nobili, F. M., Barnden, L. R., Guerra, U. P., Bonetti, M., & Frisoni, G. B. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0631-7 · Cited by 98
Herrmann, N., Rabheru, K., Wang, J., & Binder, C. E. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.6.527 · Cited by 96
Heterogeneity in Executive Impairment in Patients with Very Mild Alzheimer’s Disease
Stokholm, J., Vogel, A., Gade, A., & Waldemar, G. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093262 · Cited by 93
Frontal lobe hypoperfusion and depressive symptoms in Alzheimer disease
Levy‐Cooperman, N., Burhan, A. M., Rafi‐Tari, S., Kusano, M., Ramirez, J., Caldwell, C., & Black, S. E. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0822 · Cited by 93
Biochemical Characterization of the γ-Secretase Activity That Produces β-Amyloid Peptides
Zhang, L., Song, L., Terracina, G., Liu, Y., Pramanik, B., & Parker, E. M. (2001) · Biochemistry · doi:10.1021/bi0028800 · Cited by 93
Verbal and spatial memory spans in Alzheimer's and multi-infarct dementia
Carlesimo, G. A., Fadda, L., Lorusso, S., & Caltagirone, C. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01648.x · Cited by 92
Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ Secretion
Hiltunen, M. O., Lu, A., Thomas, A. V., Romano, D., Kim, M., Jones, P., Xie, Z., Kounnas, M. Z., Wagner, S. L., Berezovska, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603106200 · Cited by 92
Bayley, P. J., Salmon, D. P., Bondi, M. W., Bui, B. K., Olichney, J., Delis, D. C., Thomas, R. G., & Thal, L. J. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700633040 · Cited by 91
Re-assessing the relationship between cholesterol, statins and Alzheimer's disease
Wolozin, B. L., Manger, J., Bryant, R. A., Cordy, J. M., Green, R. C., & McKee, A. C. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00687.x · Cited by 90
Visuospatial Deficit in Dementia of the Alzheimer Type
Kaskie, B. P., & Storandt, M. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280120025 · Cited by 90
Apolipoprotein E modulates γ‐secretase cleavage of the amyloid precursor protein
Irizarry, M. C., Deng, A., Lleo, A., Berezovska, O., Von Arnim, C. A. F., Martin‐Rehrmann, M., Manelli, A., LaDu, M. J., Hyman, B. T., & Rebeck, G. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02581.x · Cited by 89
Neuropathology of Alzheimer's Disease
Mott, R. T., & Hulette, C. M. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.003 · Cited by 86
Santa‐María, I., Hernández, F., Rio, J. D., Moreno, F. J., & Ávila, J. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-17 · Cited by 86
Visual and spatial perception in the early phase of Alzheimer's disease.
Binetti, G. G., Cappa, S. F., Magni, E., Padovani, A., Bianchetti, A., & Trabucchi, M. (1998) · Neuropsychology · doi:10.1037//0894-4105.12.1.29 · Cited by 85
Verbal and nonverbal fluency in patients with probable Alzheimer's disease.
Mickanin, J., Grossman, M., Onishi, K., Auriacombe, S., & Clark, C. M. (1994) · Neuropsychology · doi:10.1037/0894-4105.8.3.385 · Cited by 84
Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy.
Gervais, F., Chalifour, R. J., Garceau, D., Kong, X., Laurin, J., McLaughlin, R. W., Morissette, C., & Paquette, J. (2001) · PubMed · Cited by 83
Magnetic resonance imaging of Alzheimer’s disease
Lehéricy, S., Marjańska, M., Mesrob, L., Sarazin, M., & Kinkingnéhun, S. (2006) · European Radiology · doi:10.1007/s00330-006-0341-z · Cited by 82
The evolution of dysgraphia in Alzheimer’s disease
Forbes‐McKay, K., Shanks, M. F., & Venneri, A. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.11.005 · Cited by 81
The proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain
Stockley, J. H., & O’Neill, C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350574 · Cited by 81
Alzheimer disease constricts the dynamic range of spatial attention in visual search
Parasuraman, R., Greenwood, P. M., & Alexander, G. E. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(00)00024-5 · Cited by 79
Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients
Shimabukuro, J., Awata, S., & Matsuoka, H. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01371.x · Cited by 79
Nagahama, Y., Okina, T., Suzuki, N., Matsuzaki, S., Yamauchi, H., Nabatame, H., & Matsuda, M. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000070683 · Cited by 76
A comparison of verbal and written language in Alzheimer’s disease
Groves-Wright, K., Neils‐Strunjas, J., Burnett, R. A., & O’Neill, M. J. (2003) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2003.08.004 · Cited by 75
N400 evidence of abnormal responses to speech in Alzheimer's disease
Ford, J. M., Woodward, S. H., Sullivan, E. V., Isaacks, B. G., Tinklenberg, J. R., Yesavage, J. A., & Roth, W. T. (1996) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(96)95049-x · Cited by 73
Processing of Amyloid Precursor Protein and Amyloid Peptide Neurotoxicity
Pierrot, N., & Jean-Noël, O. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954721 · Cited by 72
Ideomotor apraxia in patients with dementia of alzheimer type
Sala, S. D., Lucchelli, F., & Spinnler, H. R. (1987) · Journal of Neurology · doi:10.1007/bf00314108 · Cited by 72
Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease
Kircher, T. T. J., Erb, M., Grodd, W., & Leube, D. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.1006 · Cited by 72
Rockwood, K. J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00688.x · Cited by 72
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor
Iserloh, U., Pan, J., Stamford, A. W., Kennedy, M. E., Zhang, Q., Zhang, L., Parker, E. M., McHugh, N. A., Favreau, L. V., Strickland, C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.053 · Cited by 70
Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?
Sunderland, T., Hampel, H. J., Takeda, M., Putnam, K. T., & Cohen, R. M. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291088 · Cited by 68
The ABC of Alzheimer's Disease: Behavioral Symptoms and Their Treatment
Grossberg, G. T. (2002) · International Psychogeriatrics · doi:10.1017/s1041610203008652 · Cited by 68
α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy
Fahrenholz, F., & Postina, R. (2006) · Neurodegenerative Diseases · doi:10.1159/000095264 · Cited by 67
Lowndes, G., & Savage, G. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9032-z · Cited by 66
Neurodegeneration and Alzheimer’s disease: the lesson from tauopathies
Sorrentino, G., & Bonavita, V. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0789-x · Cited by 66
Noninvasive perfusion MRI in Alzheimer's disease
Sandson, T. A., O’Connor, M. G., Sperling, R. A., Edelman, R. R., & Warach, S. J. (1996) · Neurology · doi:10.1212/wnl.47.5.1339 · Cited by 66
Neurobiologic Bases of Noncognitive Behavioral Problems in Alzheimer Disease
Raskind, M. A., & Peskind, E. R. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199404000-00005 · Cited by 60
Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type
Shinosaki, K., Nishikawa, T., & Takeda, M. (2000) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2000.00773.x · Cited by 60
Visual object recognition in early Alzheimer's disease: deficits in semantic processing
Laatu, S., Revonsuo, A., Jäykkä, H., Portin, R. I., & Rinne, J. O. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00097.x · Cited by 58
Iragui, V. J., Kutas, M., & Salmon, D. P. (1996) · PubMed · Cited by 58
Frontal Dysfunction Underlies Depressive Syndrome in Alzheimer Disease: A FDG-PET Study
Lee, D. Y., Choo, I. H., Jhoo, J. H., Kim, K. W., Youn, J. C., Lee, D. S., Kang, E. J., Lee, J. S., Kang, W. J., & Woo, J. I. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000214541.79965.2d · Cited by 58
Blomqvist, M. E.-L., Chalmers, K. A., Andreasen, N., Bogdanović, N., Wilcock, G. K., Cairns, N. J., Feuk, L., Brookes, A. J., Love, S., Blennow, K., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.011 · Cited by 58
Clinical applications of cognitive event-related potentials in Alzheimer's disease
Olichney, J., & Hillert, D. G. (2004) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(03)00103-7 · Cited by 57
Acquisition and Long-Term Retention of a Fine Motor Skill in Alzheimers-Disease
Dick, M. B., Nielson, K. A., Beth, R. E., et al. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1283 · Cited by 56
Conceptual apraxia and semantic memory deficit in Alzheimer's disease: Two sides of the same coin?
Dumont, C., Ska, B., & Joanette, Y. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700666079 · Cited by 55
Perceptual Attention in Aging and Dementia Measured by Gottschaldt's Hidden Figure Test
Capitani, E., Sala, S. D., Lucchelli, F., Soave, P.-D. A., & Spinnler, H. R. (1988) · Journal of Gerontology · doi:10.1093/geronj/43.6.p157 · Cited by 55
Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
Pomara, N., Greenberg, W. M., Greenberg, W. M., Doraiswamy, P. M., Branford, M. D., Doraiswamy, A. P. M., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4190 · Cited by 54
Houston, W. S., Delis, D. C., Lansing, A. E., Jacobson, M. W., Cobell, K., Salmon, D. P., & Bondi, M. W. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705051015 · Cited by 54
Memapsin 2 (Beta-Secretase) Inhibitors: Drug Development
Ghosh, A. K., Kumaragurubaran, N., Ling, H., Koelsch, G., & Tang, J. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954730 · Cited by 54
Bonte, F. J., Harris, T. S., Roney, C. A., & Hynan, L. S. (2004) · PubMed · Cited by 54
Plassman, B. L., Khachaturian, A. S., Townsend, J. J., Ball, M. J., Steffens, D. C., Leslie, C., Tschanz, J. T., Norton, M. C., Burke, J. R., Welsh-Bohmer, K. A., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.001 · Cited by 52
Hormone Replacement Therapy and Cognition
LeBlanc, E. S., Chan, B. K. S., & Hd, N. (2002) · Cited by 51
M1 Muscarinic Agonists Target Major Hallmarks of Alzheimers Disease – an Update
Fisher, A. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018163 · Cited by 51
Feyt, C., Kienlen‐Campard, P., Leroy, K., N’Kuli, F., Courtoy, P. J., Brion, J., & Octave, J. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501610200 · Cited by 50
BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
Seabrook, G. R., Ray, W. J., Shearman, M. S., & Hutton, M. L. (2007) · Molecular Interventions · doi:10.1124/mi.7.5.8 · Cited by 50
Mayer, L. S., Bay, R. C., Politis, A. M., Steinberg, M., Steele, C., Baker, A. S., Rabins, P. V., & Lyketsos, C. G. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1583 · Cited by 50
Neuropathology of Alzheimer’s disease
Masters, C. L. (2005) · CRC Press eBooks · doi:10.1201/b13239-40 · Cited by 50
Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction
Matsuda, H., Kanetaka, H., Ohnishi, T., Asada, T., Imabayashi, E., Nakano, S., Katoh, A., & Tanaka, F. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0930-2 · Cited by 47
Zandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Saykin, A. J., Janssen, R. S., Sprehn, G. C., Kaplan, J. E., Spira, T. J., & O'Connor, B. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.3.286 · Cited by 47
Fox, L. S., Olin, J. T., Erblich, J., Ippen, C. G., & Schneider, L. S. (1998) · International Journal of Geriatric Psychiatry · Cited by 46
Hooijer, C., Jonker, C., Posthuma, J., & Visser, S. L. (1990) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(90)90094-z · Cited by 46
Premorbid intelligence estimation and level of dementia in Alzheimer's disease
Maddrey, A. M., Cullum, C. M., Weiner, M., & Filley, C. M. (1996) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700001727 · Cited by 44
Event-related brain potential evidence of spared knowledge in Alzheimer's disease.
Ford, J. M., Askari, N., Gabrieli, J. D. E., Mathalon, D. H., Tinklenberg, J. R., Menon, V., & Yesavage, J. A. (2001) · Psychology and Aging · doi:10.1037/0882-7974.16.1.161 · Cited by 44
Executive functions and Alzheimer's disease: problems and prospects
Patterson, M. B., Mack, J. L., Geldmacher, D., & Whitehouse, P. J. (1996) · European Journal of Neurology · doi:10.1111/j.1468-1331.1996.tb00182.x · Cited by 44
Preserved priming across study-test picture transformations in patients with Alzheimer's disease.
Park, S. M., Gabrieli, J. D. E., Reminger, S. L., Monti, L. A., Fleischman, D. A., Wilson, R. S., Tinklenberg, J. R., & Yesavage, J. A. (1998) · Neuropsychology · doi:10.1037//0894-4105.12.3.340 · Cited by 43
Ideomotor apraxia in Alzheimer's disease
Travniczek-Marterer, A., Danielczyk, W., Simányi, M., & Fischer, P. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb04176.x · Cited by 43
Smith, M., Esiri, M. M., Barnetson, L. P. D., King, E., & Nagy, Z. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051270 · Cited by 42
Electroencephalography as a Diagnostic Tool in Dementia
Rosén, I. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106615 · Cited by 42
Psychotic symptoms, aggression and restlessness in dementia
Ballard, C. G., Gray, A., & Ayre, G. (1999) · PubMed · doi:10.25405/ncl.34661118 · Cited by 38
Verbal memory decline in Alzheimer's disease
Pépin, E., & Eslinger, P. J. (1989) · Neurology · doi:10.1212/wnl.39.11.1477 · Cited by 37
The Disturbances of Object Vision and Spatial Vision in Alzheimer's Disease
Fujimori, M., Imamura, T., Yamashita, H., Hirono, N., & Mori, E. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106635 · Cited by 37
Evaluation of Genetic Tests: APOE Genotyping for the Diagnosis of Alzheimer Disease
McCONNELL, L. M., Sanders, G. D., & Owens, D. K. (1999) · Genetic Testing · doi:10.1089/gte.1999.3.47 · Cited by 36
The neuropsychological diagnosis of Alzheimer's disease
Storey, E., Kinsella, G., & Slavin, M. J. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3302 · Cited by 35
Guérin, F., Belleville, S., & Ska, B. (2002) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.24.1.1.963 · Cited by 35
Apraxia and motor-skill acquisition in Alzheimersdisease are dissociable
Jacobs, D. H. (1999) · Neuropsychologia · doi:10.1016/s0028-3932(98)00139-0 · Cited by 35
Rosén, I., Gustafson, L., & Risberg, J. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107294 · Cited by 35
"Closing-in" phenomenon in Alzheimer's disease and subcortical vascular dementia
Kwak, Y. T. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-3 · Cited by 34
Ideomotor and ideational apraxia in alzheimer's disease
Lucchelli, F., López, O. L., FAGLIONI, P., & Boller, F. (1993) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930080508 · Cited by 34
Impaired spelling in Alzheimers disease: a linguisticdeficit?
Glosser, G., Kohn, S. E., Sands, L. P., Grugan, P., & Friedman, R. B. (1999) · Neuropsychologia · doi:10.1016/s0028-3932(98)00142-0 · Cited by 30
Perceptual organization in Alzheimer's disease.
Kurylo, D. D., Corkin, S., & Growdon, J. H. (1994) · Psychology and Aging · doi:10.1037/0882-7974.9.4.562 · Cited by 29
P300 and Alzheimer's disease: oddball task difficulty and modality effects.
Polich, J. M., & Pitzer, A. J. (1999) · PubMed · Cited by 25
SLEEP AND COGNITION IN PEOPLE WITH ALZHEIMER'S DISEASE
Cole, C. S., & Richards, K. C. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840591008258 · Cited by 24
Psychiatric Reactions during Tricyclic Treatment of the Elderly Reconsidered
Meyers, B. S., & Mei-Tal, V. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198302000-00002 · Cited by 22
BARZOTTI, T., GARGIULO, A., MAROTTA, M. G., Tedeschi, G., Zannino, G. D., GUGLIELMI, S., DELL’ARMI, A., Ettorre, E., & Marigliano, V. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.04.010 · Cited by 19
The Von Restorff effect in ageing and Alzheimer’s disease
Vitali, P., Minati, L., Chiarenza, G. A., Brugnolo, A., Girtler, N. G., Nobili, F. M., Leo, C., Rosati, P., & Rodríguez, G. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0662-3 · Cited by 19
Self-citationAtypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello, L. A. (2007) · PubMed · Cited by 16
The role of neurofibrillary tangles in Alzheimer disease.
Brion, J. (1998) · PubMed · Cited by 14
Regulation of the lipidation of β-secretase by statins
Parsons, R. B., Farrant, J. K., Price, G., Subramaniam, D., & Austen, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350577 · Cited by 14
Tratamiento de los síntomas no cognitivos de la enfermedad de Alzheimer
Jm, G.-V. (2006) · Revista de Neurología · doi:10.33588/rn.4208.2005217 · Cited by 11
Laboratory biomarkers in Alzheimer’s disease
Steinerman, J. R., & Honig, L. S. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0059-6 · Cited by 10
Neurochemical approaches to the treatment of senile dementia.
Growdon, J. H., & Suzanne Corkin, A. (1980) · PubMed · Cited by 9
Mintzer, J. E., Wilcock, G. K., Black, S. E., Zavitz, K. H., Hendrix, S. B., & MPC–7869 Phase 2 Study Investigators (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1253 · Cited by 8
Das EEG als Indikator des cholinergen Defizits bei der Alzheimerschen Krankheit
Adler, G. (2000) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2000-11803 · Cited by 7
Upper and Lower Face and Ideomotor Apraxia in Patients with Alzheimer’s Disease
Capone, J. G., Sala, S. D., Spinnler, H. R., & Venneri, A. (2002) · Behavioural Neurology · doi:10.1155/2003/518959 · Cited by 7
Part VII. Treatment of neuropsychiatric symptoms in alzheimer's disease
Knopman, D. S. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90008-7 · Cited by 3
Zavitz, K. H., Hendrix, S. B., Laughlin, M. A., & Swabb, E. A. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.231 · Cited by 2
Cited by
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Resting-state brain networks: literature review and clinical applications
Rosazza, C., & Minati, L. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0636-y · Cited by 514
Self-citationMulti-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis
Initiative, T. A. D. N., Liu, M., Cheng, D., Wang, K., & Wang, Y. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9370-4 · Cited by 400
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 394
Metadata
- Authors
- Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G.
- Venue
- American Journal of Alzheimer's Disease & Other Dementias®
- Publisher
- SAGE Publications
- Published
- 2009-04
- Volume
- 24
- Issue
- 2
- Pages
- 95-121
- ISSN
- 0888-4897 (ISSN-L)
- 1533-3175
- 1938-2731
- OpenAlex
- W1997858799
- Cited by
- 268
- References
- 327
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.